You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Claims for Patent: 9,713,607


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,713,607
Title:Salinosporamides and methods of use thereof
Abstract: The present invention is based on the discovery that certain fermentation products of the marine actinomycete strains CNB392 and CNB476 are effective inhibitors of hyperproliferative mammalian cells. The CNB392 and CNB476 strains lie within the family Micromonosporaceae, and the generic epithet Salinospora has been proposed for this obligate marine group. The reaction products produced by this strain are classified as salinosporamides, and are particularly advantageous in treating neoplastic disorders due to their low molecular weight, low IC.sub.50 values, high pharmaceutical potency, and selectivity for cancer cells over fungi.
Inventor(s): Fenical; William (Del Mar, CA), Jensen; Paul (San Diego, CA), Mincer; Tracy (San Diego, CA), Feling; Robert H. R. (Wiesbaden, DE)
Assignee: The Regents of the University of California (Oakland, CA)
Application Number:14/794,468
Patent Claims:1. A pharmaceutical composition comprising a pharmaceutically acceptable carrier and an effective amount of a compound having the structure: ##STR00014##

2. The pharmaceutical composition of claim 1, wherein the composition further comprises sucrose.

3. The pharmaceutical composition of claim 1, wherein the composition further comprises an anti-neoplastic agent.

4. The pharmaceutical composition of claim 3, wherein the additional anti-neoplastic agent is selected from an antimetabolite, an alkylating agent, a plant alkaloid, an antibiotic, a hormone and an enzyme.

5. The pharmaceutical composition of claim 3, wherein the antimetabolite is selected from methotrexate, 5-fluorouracil, 6-mercaptopurine, cytosine arabinoside, hydroxyurea and 2-chlorodeoxyadenosine.

6. The pharmaceutical composition of claim 3, wherein the alkylating agent is selected from cyclophosphamide, melphalan, busulfan, paraplatin, chlorambucil and nitrogen mustard.

7. The pharmaceutical composition of claim 3, wherein the plant alkaloid is selected from vincristine, vinblastine, taxol and etoposide.

8. The pharmaceutical composition of claim 3, wherein the antibiotic is selected from doxorubicin, daunorubicin, mitomycin c and bleomycin.

9. The pharmaceutical composition of claim 3, wherein the hormone is selected from calusterone, diomostavolone, propionate, epitiostanol, mepitiostane, testolactone, tamoxifen, polyestradiol phosphate, megesterol acetate, flutamide, nilutamide and trilotane.

10. The pharmaceutical composition of claim 3, wherein the enzyme is selected from L-asparaginase derivatives and aminoacridine derivatives.

11. The pharmaceutical composition of claim 10, wherein the aminoacridine derivative is amsacrine.

12. The pharmaceutical composition of claim 1, wherein the composition is useful for inhibiting a proliferation of cancer cells.

13. The pharmaceutical composition of claim 12, wherein the cancer cells are mammalian colon cancer cells.

14. The pharmaceutical composition of claim 1, wherein the composition is in solid form.

15. The pharmaceutical composition of claim 1, wherein the composition is in the form of a sterile injectable solution.

16. The pharmaceutical composition of claim 1, wherein injectable solution is an aqueous solution.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.